BTG PLC | Cash Flow

Fiscal year is April-March. All values GBP Thousands.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
24,300.00
33,600.00
60,500.00
33,600.00
12,700.00
Depreciation, Depletion & Amortization
27,700.00
35,000.00
44,300.00
53,300.00
55,600.00
Other Funds
700.00
1,000.00
1,100.00
20,500.00
3,400.00
Funds from Operations
51,000.00
57,900.00
101,800.00
89,800.00
92,400.00
Changes in Working Capital
2,300.00
10,500.00
6,200.00
15,600.00
28,300.00
Net Operating Cash Flow
48,700.00
47,400.00
95,600.00
74,200.00
120,700.00
Capital Expenditures
12,500.00
11,200.00
30,500.00
9,500.00
11,400.00
Sale of Fixed Assets & Businesses
3,200.00
100.00
-
-
-
Net Investing Cash Flow
269,600.00
158,800.00
29,900.00
45,300.00
56,400.00
Net Financing Cash Flow
102,700.00
146,200.00
-
19,700.00
1,000.00
Net Change in Cash
120,500.00
35,600.00
66,600.00
15,100.00
54,500.00
Free Cash Flow
37,100.00
37,600.00
89,400.00
65,300.00
110,300.00
Deferred Taxes & Investment Tax Credit
-
-
-
-
107,900.00
Net Assets from Acquisitions
260,300.00
147,700.00
-
36,200.00
45,500.00
Other Sources
-
-
600.00
400.00
500.00
Change in Capital Stock
103,400.00
147,200.00
1,100.00
800.00
2,400.00
Exchange Rate Effect
2,300.00
800.00
900.00
5,900.00
8,800.00

About BTG

View Profile
Address
5 Fleet Place
London London & South East EC4M 7RD
United Kingdom
Employees -
Website http://btgplc.com
Updated 07/08/2019
BTG Plc is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following business segments: Interventional Medicine, Pharmaceuticals, and Licensing. The Interventional Medicine segment provides therapies for cancer, sever emphysema, and vascular conditions such as severe blood clots and varicose veins.